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Abstract
Objective: To evaluate whether endometrial or ovarian parameters as measured using 3D power
Doppler ultrasound would predict the outcome in frozen embryo transfer (FET) cycles.
Methods: Thirty women with no known gynecological pathology undergoing FET were recruited.
The FET was carried out in the natural menstrual cycle 3-4 days after the first positive LH test
result. Blood samples for hormonal analysis were collected, and three-dimensional (3D)
ultrasonographic examination was performed on the day of the FET and repeated with analysis of
the total hCG one week later.
Results: The demographic, clinical, and embryological characteristics were similar between the
pregnant (15/30) and nonpregnant groups (15/30). There were no differences between the groups
in endometrial/subendometrial thickness, volume, or vascularization index (VI). The endometrial
triple-line pattern was more often present in the pregnant group on the day of the FET (93.3% vs.
40.0%, 95% CI 25.5-81.2%). No differences in the ovaries were observed on the day of the FET. At
the second visit, the triple-line pattern was still more often present in those patients who had
conceived (91.7% vs. 42.9%, 95% CI 18.5-79.1%), and their corpus luteum was more active as
judged by the rise in 17-hydroxyprogesterone and estradiol levels. No differences were observed
in the dominant ovarian vasculature.
Conclusions:  According to our results, measurement of power Doppler indices using 3D
ultrasound on the day of the FET does not provide any additional information concerning the
outcome of the cycle. The existence of the triple-line pattern on the day of the FET seems to be a
prognostic sign of a prosperous outcome after FET. The dominant ovary in the pregnant group
seems to be already activated one week after the FET.
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Background
Because of wider use of elective single embryo transfer,
frozen-thawed embryo transfers (FETs) have also become
more common. According to European data for artificial
reproductive treatment (ART) [1], 64,147 FETs were per-
formed during 2004 in Europe, and an approximate clin-
ical pregnancy rate was 19.1%. The highest rates of single
embryo transfers (SETs) from all transfers were found in
Sweden (67%), Belgium (49%), and Finland (47%) [1].
During 2005 and 2006 in Finland, the number of FETs
increased by 7% while the number of IVF and ICSI cycles
remained unchanged. In 52.7% of all the FET cycles in
Finland, only one embryo was transferred [2]. The overall
live birth rate/cycle after FET was 16.6%, and after single
embryo transfer the rate was 14.2% and 19.3% after dou-
ble embryo transfer [2]. In 2006, every fourth child born
after ART originated from an FET cycle [2], emphasizing
the role of FET cycles in Finnish ART practice.
Since less than 20% of FET cycles result in pregnancy and
live birth, it is important to evaluate factors that may affect
the treatment result. It seems that failure of implantation
remains the main reason why most treatments fail [3].
The failure of implantation may be caused by the low
quality of the embryo(s) transferred or by a nonreceptive
uterine endometrium. If the nonreceptive endometrium
could be detected before the transfer of the embryo, the
cycle could be abandoned, and the embryo(s) could be
transferred during a cycle with more favorable circum-
stances.
The ability to identify a receptive uterus prospectively by a
noninvasive method would have an invaluable clinical
impact on treatment efficiency and success rates. Ultra-
sonographic examination offers us a noninvasive method
to evaluate the uterine environment before embryo trans-
fer. Several sonographic parameters have been proposed
for assessing endometrial receptivity, including endome-
trial thickness, endometrial pattern, endometrial volume,
and endometrial and subendometrial blood flow [4-7].
The aim of this prospective study was to evaluate whether
any of the endometrial or ovarian parameters measured
using 3D power Doppler ultrasound before the transfer of
frozen and thawed embryos have an impact on the out-
come of the cycle. The ultrasonographic parameters of the
endometrium and ovaries were correlated with the sys-
temic steroid concentrations. In addition, we wanted to
evaluate whether these parameters differed one week after
embryo transfer--at the time of presumed implantation--
between those who conceived and those who did not.
Methods
We recruited 30 women undergoing frozen-thawed
embryo transfer (FET) during a natural menstrual cycle
between May 2004 and February 2008 in the Assisted
Reproduction Unit of the Department of Obstetrics and
Gynecology, Oulu University Hospital, Finland. The study
was approved by the Ethics Committee of Oulu University
Hospital, Oulu, Finland. Informed written consent was
obtained from all participants, after the nature of the pro-
cedures had been fully explained. Inclusion criteria were
women with no known gynecological pathology (e.g.,
known endometriosis, fibroids, any previous operation to
gynecological organs). For the study, the patients were
examined on the day of the FET and 5-9 days later. Blood
samples for hormonal assays were collected, and three-
dimensional (3D) ultrasonographic examination was per-
formed during both visits.
Indication for previous IVF or ICSI treatment included
male, tubal, anovulation, endometriosis, mixed, and
unexplained factors. ICSI was performed for 16 couples
with severe semen abnormalities (Table 1). The details of
the long protocol for ovarian stimulation have been
described previously [5]. During the IVF/ICSI treatment,
the excess embryos were frozen after culture for two days
using a slow-freezing protocol with 1,2-propanediol as
cryoprotectant [8].
In the FET cycles, ovulation occurred spontaneously, with-
out any kind of hormonal treatment. According to the FET
protocol used in our clinic, the transvaginal ultrasono-
graphic examination was carried out during cycle days 10-
12, and the side and size of the dominant follicle and
endometrial thickness were recorded. Endometrial thick-
ness was measured as the thickest part in the longitudinal
section, including both endometrial layers. After the ultra-
sonographic examination, the women started luteinizing
hormone (LH) tests on urine samples every morning to
confirm ovulation (home test kit, Clearplan; Unipath,
Bedford, UK). The embryo transfer was carried out 3-4
days after the first positive LH test result. A maximum of
two embryos were transferred. The thawed embryos were
graded using the same criteria as in the fresh cycles [9]. A
top-quality embryo was defined as having four blast-
omeres on day 2 or ≥ 8 blastomeres on day 3, less than
20% fragmentation, and no multinuclear blastomeres.
After the transfer, the patients started to use 200 mg of
progesterone twice a day either per os or intravaginally,
depending on their preference. In case of pregnancy, the
progesterone treatment was continued up to pregnancy
week 10.
The 3D transvaginal ultrasound measurements (Voluson
Expert 730, Kretz, Zipf, Austria) were performed on the
day of the FET and repeated about one week later, at the
time of the expected implantation. The results of the ultra-
sound examination did not affect subsequent clinical
management procedures. The 3D ultrasound technique
enabled the determination of endometrial, subendome-Reproductive Biology and Endocrinology 2009, 7:151 http://www.rbej.com/content/7/1/151
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trial, and ovarian volume, including possible changes in
the vascular network. Identical preinstalled instrument
settings (frequency, mid; dynamic set, 2; balance, G>170;
smooth, 5/5; ensemble, 16; line density, 7; power Dop-
pler map, 5; and the setting conditions for the power Dop-
pler mode were gain, -5.6; quality, normal; wall motion
filter, low 1; peak repetitive frequency PRF, 0.9 kHz) were
applied for all patients. At the second visit, the power
Doppler mode was not used to examine the uterus.
During the ultrasound examination, the uterus was first
visualized in two-dimensional (2D) B-mode after the
patient had emptied her bladder. The power Doppler
mode was switched on, and the power Doppler box was
positioned to cover the whole uterus. The 3D facility was
engaged by switching to 'volume mode.' The volume sec-
tor angle was preset to 80°, and the fast volume acquisi-
tion (low-resolution) setting was selected to avoid
artifacts. Thereafter, the ovaries were examined similarly.
The ultrasonographic volume data were saved on the hard
drive and analyzed later using the built-in virtual organ
computer-aided analysis imaging program (VOCAL, GE
Healthcare, Zipf, Austria) for 3D power Doppler histo-
gram analysis. The manual mode of the VOCAL Contour
Editor was used to cover the whole 3D volume of the
region of interest (ROI), with 15° rotation steps. Hence,
12 contour planes were analyzed for each ROI to cover
360°. After obtaining the total volume of the ROI, the
program calculated the ratio of color voxels to all the vox-
els; this ratio (%) was expressed as the vascularization
index (VI). The vascularized volume (unit mL) in the
endometrium or in the ovary was calculated by multiply-
ing the total volume of the ROI by its VI. The VOCAL pro-
gram automatically calculated the index for mean
grayness (MG) in the ROI, which presents the average
grayness in the gray-scale voxels [10].
The endometrial thickness, including both endometrial
layers, was measured at its thickest in the longitudinal sec-
tion. The endometrial pattern was assessed from the same
section and described as triple-line or homogeneous. The
echogenity of the endometrium in comparison with the
subendometrium was evaluated with two different meth-
ods. First, a single observer (T.Z.) evaluated the endome-
trial echogenity subjectively and categorized it as either
hyperechoic, homoechoic, or hypoechoic in comparison
with the myometrial echogenity. In the second method,
we used the MG values supplied by the VOCAL. The MGen-
dom is the mean gray value in the endometrium, and the
MGsubendom  is the mean gray value in the suben-
dometrium. The subendometrial volume was calculated
after we had defined the subendometrial region as the
region 5 mm beneath the myometrial-endometrial junc-
tion. The reproducibility of the volume and color index
measurements using transvaginal 3D power Doppler
ultrasound has been determined [11]. The reproducibility
of volume and color index measurements using transvag-
inal 3D power Doppler ultrasound has been determined
by Järvelä et al 2003 [11]. The intraobserver correlation
coefficient for volume measurements was 1.0 and for VI it
was 0.898[11].






Age (years) 31,3 ± 1,1 31,5 ± 1,1 0,905
BMI (kg/m2) 22,9 ± 1,1 23,0 ± 0,8 0,941
Partus 0,2 ± 0,1 0,5 ± 0,3 0.372
Grav 0,5 ± 0,2 0,5 ± 0,3 0.843
Causes of infertility; n (%)
Male 8(53,3) 10 (66,7) 0.738
Tubal 1(6,7) 1 (6,7)
Anovulation 1(6,7) 0 (0)
Endometriosis 2 (13,3) 1 (6,7)
Mixed 0 (0) 1 (6,7)
Unexplained 3 (20,0) 2 (13,3)
Number of previous IVF 1,5 ± 0,3 1,7 ± 03 0.853
Number previous FET 0,9 ± 0,3 0,9 ± 0,2 0.533
Number of transfered embryos; n (%) 1,5 ± 0,1 1,5 ± 0,1 1.000
Insemination Method; n (%) 0.075
IVF 10 (66,7) 4(26,7)
ICSI 5 (33,3) 11(73,3)
LH test positive, cycle day 14,7 ± 0,5 13,8 ± 0,7 0,246
Embryotransfer, cycle day 18,0 ± 0,6 17,2 ± 0,6 0,368
Values are mean ± SEM or n (%).
No statistically significant differences were observed between the pregnant and nonpregnant groups.Reproductive Biology and Endocrinology 2009, 7:151 http://www.rbej.com/content/7/1/151
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Assays
The blood samples for analysis of serum progesterone (P),
17-hydroxyprogesterone (17-OHP), and estradiol (E2)
were collected on the day of the FET and repeated about
one week later with the analysis of total human chorionic
gonadotrophin (hCG). Clinical pregnancy was confirmed
by ultrasonography after a positive urinary pregnancy test
and visible heartbeat at pregnancy week 7.
Serum concentrations of P and total hCG were measured
by an automated chemiluminescence system (Advia Cen-
taur, Bayer Corporation, NY, USA), 17OHP by radioim-
munoassay (Diagnostic Products Corporation, LA, USA),
and E2by radioimmunoassay (Orion Diagnostica, Oulun-
salo, Finland), following the instructions provided by the
manufacturers.
The intra-assay and the interassay coefficients of variation
were 3.7% and 5.4% for P, 5.0% and 5.4% for 17-OHP,
2.0% and 3.5% for hCG, and 5.7% and 6.4% for E2. Exter-
nal quality control of the hormone assays was organized
by national (Labquality Ltd., Helsinki, Finland) and inter-
national (Bio-Rad Laboratories EQAS, Irvine, CA) compa-
nies.
Statistics
Statistical analysis was performed using the Statistical
Package for the Social Sciences (Release 16.0, SPSS Inc.,
Chicago, IL, USA). Departure from a normal distribution
was assessed using the Kolmogorov-Smirnov test. For
paired comparisons, the paired t-test for normal data or
Wilcoxon's test for skewed data was used. Correlation was
estimated using Pearson's correlation coefficient. Propor-
tions were compared using the chi-square test. A p-value
(two-tailed) of < 0.05 was considered significant.
Results
A total of 30 women undergoing FET were recruited for
the study. Four patients missed the second set of measure-
ments. The pregnancy rate was 50% (15/30). For statisti-
cal analysis, the women were divided into two groups
according to whether or not they had conceived. These
two groups did not differ from each other in demo-
graphic, clinical, or embryological characteristics (Table
1).
There were no differences between the pregnant and non-
pregnant groups in the 3D-ultrasound characteristics of
the ovaries and serum steroid levels on the day of the FET
(Table 2). The endometrial triple-line pattern was more
often present in the pregnant group on the day of the FET
(93.3% vs. 40.0%, p-value of chi-square test 0.005). In the
group of triple-line patients, the pregnancy rate was 70%
(14/20), while for the group with the homoechogenic
endometrium, the pregnancy rate was only 10% (1/10).
The patients were further divided into two groups accord-
ing to an endometrial cutoff volume of 2 ml. In the group
of patients whose endometrial volume was more than 2
ml, the pregnancy rate was 55% (12/22), whereas in the
group whose volume was less than 2 ml, the rate was 38%
(3/8) (NS).
The endometrial echogenity at the time of the FET was
evaluated using two methods (Table 2). First, a single
observer evaluated subjectively the endometrial echogen-
ity and categorized it as either hyperechoic, homoechoic,
or hypoechoic in comparison with the subendometrial
(myometrial) echogenity. In the second method, we used
the mean gray (MG) values that were calculated by
VOCAL for both the endometrial and subendometrial vol-
umes. The MGendom  is the mean gray value in the
endometrium, and the MGsubendom is the mean gray value
in the subendometrium. The difference (MGendom - MGsub-
endom) ranged from 0.37 to 15.87 (mean 6.36 ± 0.91) and
was above 0 in all cases. The subjective evaluation resulted
exactly in the same finding as the method using VOCAL,
i.e., the endometrium was more echogenic in the ultra-
sound than the subendometrium.
The characteristics and outcomes of the treatment cycles
about one week after the FET, at the time of expected
implantation, are given in Table 3. Four patients (three
pregnant and one nonpregnant) missed the second set of
measurements for personal reasons. During the second
examination, the power Doppler mode was not used to
investigate the uterus, and therefore, the data concerning
the endometrium/subendometrium does not include any
power Doppler information. The triple-line pattern was
still more often present in those patients who conceived
(91.7% vs. 42.9%, 95% CI for the difference between pro-
portions 18.5%-79.1%). The endometrium was also sig-
nificantly thicker in the pregnant group at this stage. No
differences were observed in the dominant or in the non-
dominant ovarian vasculature parameters between the
pregnant and nonpregnant groups. The pregnant group
had significantly higher 17-OHP (p 0,009) and estradiol
levels (p 0,039) than the nonpregnant group one week
after the FET. Out of those 12 patients who finally con-
ceived and were examined twice, 6 had a positive hCG
pregnancy test at the 2nd measurement, which took place
7.2 ± 0.2 days after the FET. Another 6 patients were tested
negative at their second visit (5.3 ± 0.4 days after the FET),
but they showed a positive result of hCG pregnancy test
later.
The change of ultrasonographic and serum hormone lev-
els between the first and second examination was also
compared (Table 4). In the 12 pregnant patients, there
was an increase in P- and 17-OHP levels and in endome-
trial thickness. In the 6 patients with a positive pregnancyReproductive Biology and Endocrinology 2009, 7:151 http://www.rbej.com/content/7/1/151
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test at the second visit, a similar rise in P- and 17-OHP lev-
els and in endometrial thickness was also observed (Table
4). Another 6 patients were tested negative at their second
visit, but they showed a positive result of hCG pregnancy
test later, only their P levels rose between the day of FET
and the day of the second visit (Table 4).
In the group of 14 nonpregnant women, the P levels rose,
after the FET and the dominant ovarian volume decreased
from 15,9 ml ± 1.9 to 12.5 ml ± 1.8 (p 0,034). In the
patients who became pregnant after FET (n = 12), no
changes were observed in the dominant ovarian volume
or vascularization.
Discussion
The aim of the study was to evaluate whether some of the
endometrial or ovarian characteristics before the transfer
of frozen and thawed embryo(s) during a spontaneous
menstrual cycle predicted the outcome of the FET cycle. At
the time of embryo transfer, the only and the most prom-
inent feature in patients who finally conceived was the
presence of a triple-line pattern in the endometrium. Oth-
erwise, the patients did not differ in terms of endometrial/
subendometrial thickness, volume, or vascularization.
Neither the ultrasonographic characteristics in the domi-
nant ovary nor the serum hormonal levels differed
between pregnant and nonpregnant subjects at the time of
embryo transfer. One week after the transfer, we observed
opposite changes in the corpus luteal activity between the
successful and unsuccessful cycles.
The presence of a triple-line pattern in the endometrium
at FET was strongly associated with the outcome of the
cycle. A triple-line pattern reflects endometrial prolifera-
tion, and the absence may be a sign of premature secretory
changes in the endometrium, suggesting that the time of
maximal endometrial receptivity has already passed [12].
Several earlier studies have also observed that a triple-line
pattern in the endometrium before embryo transfer is a
favorable sign, although in these studies the endometrial
pattern was assessed after fresh embryo transfers follow-
ing controlled ovarian stimulation (COH) [10,13-15].







Endometrial thickness (mm) 11,1 ± 0,3 11,2 ± 0,7 0,882
Endometrial Volume (ml) 3,7 ± 0,4 3,4 ± 0,7 0,669
Endometrial pattern triple line
(n, %)
0.005
Homoechogenic 1 (6,7) 9 (60,0)
Tripple line 14 (93,3) 6 (40,0)
Endometrial vascularization index (VI) % 0,9 ± 0,3 1,1 ± 0,4 0,661
Endometrial vascularization**
(ml)
0,04 ± 0,02 0,04 ± 0,02 0,887
Subendometrial Volume (ml) 11,2 ± 0,9 11,3 ± 1,2 0.996
Subendometrial vascularization index(VI) % 4,1 ± 1,7 1,2 ± 0,4 0,110
Subendometrial vascularization**
(ml)
0,5 ± 0,1 0,2 ± 0,1 0,075
Endometrial echogenity*
Subjective evaluation (n,%)
Hyperechogenic 15 (100) 15 (100)
Hypoechogenic 0 (0) 0 (0)
MG endsubend 1,24 ± 0.05 1,25 ± 0,06 0,917
MG subend 29,25 ± 1,60 26,95 ± 2,56 0,453
Dominant -ovary Volume (ml) 17,0 ± 2,9 15,1 ± 1,8 0,562
Dominant ovary vascularization index (VI) % 9,2 ± 1,5 7,6 ± 1,1 0,382
Dominant ovary vascularization** (ml) 1,4 ± 0,2 1,0 ± 0,1 0.134
Nondominant ovary Volume (ml) 9,0 ± 1,1 7,8 ± 0,7 0,376
Nondominant-ovary vascularization index(VI) % 3,7 ± 0,7 5,2 ± 1,2 0,287
Nondominant ovary vascularization** (ml) 0,4 ± 0,1 0,4 ± 0,1 0,725
Progesterone on the day of FET (nmol/l) 25,4 ± 3,2 45,9 ± 12,7 0,130
17-OHP on the day of FET (nmol/l) 8,6 ± 0,4 9,6 ± 0,8 0,263
Estradiol on the day of FET (nmol/l) 0,31 ± 0,02 0,33 ± 0,03 0,695
Values are mean ± SEM or n (%).
*The echogenity of the endometrium in comparison with subendometrium was evaluated by two different methods, which were subjective analysis 
and mean gray (MG) -value supplied by VOCAL.
MGendom, mean gray value in the endometrium; MGsubendom mean gray value in the subendometrium. **Vascularization, volume multiplied with VI.Reproductive Biology and Endocrinology 2009, 7:151 http://www.rbej.com/content/7/1/151
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The only earlier study in which the endometrial pattern
was assessed before FET did not find an association
between triple-line pattern and cycle outcome [16].
In most of our patients, the triple-line pattern was still vis-
ible one week after the FET, about 10 days after the posi-
tive LH test. At that time at the midluteal phase, the corpus
luteum should be actively secrete progesterone. In addi-
tion, all the patients had progesterone supplementation,
which is supposed to ensure that in case of corpus luteal
deficiency the progesterone concentrations would be high
enough. According to earlier findings, a triple-line pattern
usually should disappear during the secretory phase under
the influence of progesterone secretion[17]. It is possible
that, if the second examination in our study had taken
place later during the secretory phase, the incidence of tri-
ple-line pattern would have been lower. Interestingly, the
triple-line pattern was still at the time of implantation
more common in patients who eventually conceived.
It was in our interest to evaluate if 3D power Doppler
ultrasonography offered us a tool to predict the chances of
patients to get pregnant after FET. Since this technique
enables the accurate assessment of the volume of the
organ and the vasculature supplying the organ, we meas-
ured endometrial, subendometrial, and dominant ovar-
ian volumes and their vasculature before FET. The results
show however that this technique did not distinguish
between successful and unsuccessful cycles and may not
be useful for this purpose. This is in accordance with ear-
lier observation after fresh embryo transfer following
COH [5,14,18]. There was no difference in endometrial







Days after FET 6,3 ± 0,4 5,9 ± 0,4 0,539
Endometrial thickness (mm) 12,5 ± 0,6 10,6 ± 0,6 0,049
Endometrial Volume (ml) 4,3 ± 0,7 4,1 ± 0,9 0,925
Endometrial pattern triple line (n, %) 0.019
Homoechogenic 1(8,3) 8(57,1)
Tripple line 11(91,7) 6(42,9)
Dominant ovary Volume (ml) 15,3 ± 1,5 12,5 ± 1,8 0,255
Dominant ovary vascularization index (VI) % 10,5 ± 1,8 8,6 ± 1,63 0,446
Dominant ovary vascularization **(ml) 1,4 ± 0,2 0,9 ± 0,1 0.084
Nondominant ovary Volume (ml) 9,4 ± 1,5 8,2 ± 0,8 0,454
Nondominant ovary vascularization index(VI) % 3,3 ± 0,7 6,1 ± 1,3 0,072
Nondominant ovary vascularization **
(ml)
0,3 ± 0,1 0.5 ± 0,1 0,118
Progesterone one week after FET(nmol/l) 174,5 ± 68,0 92,3 ± 18,3 0,224
17-OHP one week after FET(nmol/l) 15,1 ± 2,1 8,3 ± 1,3 0,009
Estradiol one week after FET(nmol/l) 0,40 ± 0,06 0,25 ± 0,04 0,039
Four patients missed the second set of measurements. The power Doppler mode was not applied at any time during the visit to investigate the 
pregnancy itself (the fetus or the trophoblastic tissue). Therefore, data concerning the fetus, gestational sac, or placenta do not include any power 
Doppler information.
**Vascularization, volume multiplied with VI. Values are mean ± SEM or n (%). 17-OHP = 17 hydroxyprogesterone
Table 4: Subanalysis of serum hormone concentrations and endometrial thickness one week after FET.
Pregnant (n = 12) P Pregnant, hCG 
positive (n = 6)
PP r e g n a n t ,  h C G  




P1 25,1 ± 3,3 0.002 24,2 ± 6,5 0.005 26,0 ± 2,4 0.028 48,7 ± 13,3 0.041
P2 174,5 ± 8,0 121,2 ± 23,9 227,8 ± 136,5 92,3 ± 18,3
17-OHP1 9,0 ± 0,5 0.015 9,2 ± 0,8 0.046 8,8 ± 10,5 0.249 9,9 ± 0,8 0.300
17-OHP2 15,1 ± 2,1 16,9 ± 2,6 13,2 ± 3,3 8,3 ± 1,3
Endometrial 
thickness 1 (mm)
11,2 ± 0,4 0.006 11,4 ± 0,8 0.028 10,9 ± 0,2 0.075 11,2 ± 0,8 0.132
Endometrial 
thickness 2 (mm)
12,5 ± 0,6 12,3 ± 1,0 12,7 ± 0,9 10,5 ± 0,6
P, progesterone; 17-OHP, 17-hydroxyprogesterone; Values are mean ± SEM or n (%).
Index 1 = measurements on the day of FET, Index 2 = one week later, at the time of second visit.
P-values of the longitudinal comparison confront the characteristics on the day of FET and on the day of the second visit.Reproductive Biology and Endocrinology 2009, 7:151 http://www.rbej.com/content/7/1/151
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thickness between those who conceived and those who
did not, supporting the common opinion that measure-
ment of endometrial thickness cannot be used to predict
the likelihood of subsequent conception [19].
There were clear signs of changes in corpus luteal activity
with respect to whether the patients conceived or not. In
patients who became pregnant, the 17-OHP and E2 levels
increased, most probably reflecting the rescue of the cor-
pus luteum by hCG secreted from the trophoblastic tissue
[20]. On the contrary, in patients who failed, the domi-
nant ovarian volume decreased by the second set of meas-
urements and 17-OHP levels were lower than in pregnant
women, reflecting the continuing regression of the corpus
luteum without hCG stimulation. The P levels rose in
both groups, which probably was due to the exogenous P
substitution. It is also very unlikely that the failure of the
FET cycle was a consequence of low P levels, since no dif-
ference between the groups was observed.
The software in the 3D ultrasonographic equipment pro-
vided the determination of echogenity of the tissue by
assessing the mean gray value in the region of interest. The
use of this modality has been very rare in previous studies
[10]. Since the echogenity of the secretory endometrium is
usually higher than in the surrounding myometrium, we
assessed the echogenity in these two areas subjectively and
used software to provide the MG values. A strong correla-
tion between these two methods was observed. Future
studies will show whether this index has clinical value.
Conclusion
The triple-line pattern of the endometrium at the time of
FET was the only sign that predisposed pregnancy. Serum
steroid levels or the endometrial or ovarian characteristics
assessed using 3D power Doppler ultrasonography did
not reveal any additional benefit. Nevertheless, more
studies with a larger number of women are needed to con-
firm and extend these findings and establish a more pre-
cise cutoff value for endometrial volume, thickness, and
vascularization indices.
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